首页> 中文期刊>中外医疗 >经阴道B超对宫颈浸润癌的诊断价值探讨

经阴道B超对宫颈浸润癌的诊断价值探讨

     

摘要

目的 在宫颈浸润癌诊断中应用阴道B超,并分析其诊断价值.方法 方便选取2014年6月-2018年6月到该院进行诊断治疗的30例宫颈浸润癌患者,将其分为经阴道B超组15例、经腹部B超组15例,分别进行经阴道B超及经腹部B超检查,以术后病理检查为金标准,对比两种检查方式的诊断符合率.结果 经阴道B超诊断宫颈浸润癌病理分期符合率(93.33% vs 73.33%)、浸润深度符合率(100.00% vs 73.33%)均明显高于经腹部B超,差异有统计学意义(P<0.05).结论 经阴道B超诊断宫颈浸润癌病理分期及浸润深度符合率均明显高于常规经腹部B超,值得临床推广.%Objective To apply vaginal B ultrasound in the diagnosis of cervical invasive carcinoma and analyze its diagnostic value. Methods Convenient select from June 2014 to June 2018, 30 patients with cervical invasive cancer who were diagnosed and treated in our hospital were divided into 15 cases of transvaginal B-mode ultrasound group and 15 cases of transabdominal B-mode ultrasound group. B-ultrasound and transabdominal B-ultrasound examination, with postoperative pathological examination as the gold standard, comparing the diagnostic coincidence rate of the two examination methods. Results The coincidence rate of pathological staging of cervical invasive carcinoma (93.33% vs 73.33%) and the infiltration depth (100.00% vs 73.33%) were significantly higher than those of transabdominal B-ultrasound (P<0.05). Conclusion The coincidence rate of pathological staging and depth of invasion of cervical invasive carcinoma by transvaginal B-ultrasound is significantly higher than that of conventional transabdominal B-ultrasound, which is worthy of clinical promotion.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号